Lv51
1440 积分 2024-11-08 加入
Study on Integrated Synthesis of Dimeric Pyranonaphthoquinones: Preparation of Versatile Synthetic Intermediate and Conversion into ent-Hemi-actinorhodin and ent-Hemi-γ-actinorhodin
1小时前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
1个月前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
1个月前
已完结
Regulated bioanalysis of antibody-drug conjugates using LC-MS
2个月前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
2个月前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
2个月前
已完结
Engineering and immobilization of imine reductase enable chemoenzymatic synthesis of SLC6A19 inhibitor JNT-517
5个月前
已完结
First‐in‐human study with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5aR1) antagonist, supported by pharmacokinetic predictions from animals to patients
5个月前
已完结
Discovery and Characterization of a New Class of C5aR1 Antagonists Showing In Vivo Activity
6个月前
已完结
Synthetic Approaches to the New Drugs Approved During 2021
6个月前
已完结
皖公网安备34019202002308
